Unknown

Dataset Information

0

Pharmacotherapy versus T lymphocytes for CMV.


ABSTRACT: In this issue of Blood, Blyth et al report a phase 2 study in 50 allogeneic hematopoietic stem cell transplant (HSCT) recipients who received donorderived cytomegalovirus (CMV)-specific cytotoxic T cells (CTLs) and compare outcomes with a group of concomitant controls who were transplanted at the trial centers but who did not receive CTLs.

SUBMITTER: Heslop HE 

PROVIDER: S-EPMC3643755 | biostudies-literature | 2013 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pharmacotherapy versus T lymphocytes for CMV.

Heslop Helen E HE  

Blood 20130501 18


In this issue of Blood, Blyth et al report a phase 2 study in 50 allogeneic hematopoietic stem cell transplant (HSCT) recipients who received donorderived cytomegalovirus (CMV)-specific cytotoxic T cells (CTLs) and compare outcomes with a group of concomitant controls who were transplanted at the trial centers but who did not receive CTLs. ...[more]

Similar Datasets

| S-EPMC2118179 | biostudies-literature
2018-04-09 | GSE104750 | GEO
| S-EPMC6244284 | biostudies-literature
| S-EPMC7839363 | biostudies-literature
| S-EPMC6317445 | biostudies-literature
| S-EPMC6366655 | biostudies-literature
| S-EPMC6204997 | biostudies-literature
2015-01-18 | E-MEXP-3473 | biostudies-arrayexpress
| S-EPMC3041771 | biostudies-literature
| S-EPMC3480571 | biostudies-literature